Poxviridae Infections: Clinical Trials

201 trials for Poxviridae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

128 completed, 18 recruiting, 13 unknown, 11 active not recruiting. 60 Phase 1, 58 Phase 2, 27 Phase 3, 14 Not applicable, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 160Completed 51, Recruiting 4, Terminated 2, Withdrawn 2, Unknown 1
Phase 258Completed 43, Active not recruiting 4, Terminated 4, Recruiting 3, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 327Completed 17, Active not recruiting 4, Terminated 2, Recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Not applicable14Completed 5, Recruiting 4, Unknown 3, Enrolling by invitation 1, Not yet recruiting 1
Phase 46Completed 3, Active not recruiting 2, Unknown 1
Early Phase 12Active not recruiting 1, Withdrawn 1

Follow Poxviridae Infections: new trials by email Literature Review of Poxviridae Infections trials Research Report on Poxviridae Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Myocarditis After Replication-Deficient Smallpox Immunization
JYNNEOS - Myopericarditis, Small Pox
Not yet recruitingWomack Army Medical Center23502029-03-012023-12-14
Smart Analysis and Decision-Making for Emerging Infectious Diseases
Multi-Agent Integrated Smart Toolkit for Emerging Infectious Diseases, Routine Practices - Emerging Infectious Diseases, COVID-19
Not applicableEnrolling by invitationPeking University1082026-08-102026-08-19
Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort
blood sampling - Mpox (Monkeypox)
Not applicableNot yet recruitingANRS, Emerging Infectious Diseases602026-07-012026-05-18
Performance Evaluation of Mpox Molecular POC Diagnostics
MPOX IVD test - Monkey Pox
CompletedFoundation for Innovative New Diagnostics, Switzerland802026-06-182026-09-04
Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo
blood sample collection - Mpox
Phase 4Active not recruitingInstitute of Tropical Medicine, Belgium3002026-05-152026-06-11
Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC
SDS-EDTA-treated chromatography strip - Mpox
RecruitingUniversitaire Ziekenhuizen KU Leuven1502026-05-012026-06-11
Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea
Mpox (Monkeypox), Monkeypox
Not yet recruitingLondon School of Hygiene and Tropical Medicine9922026-04-162026-04-16
A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa
BNT166a, Placebo - Mpox (Monkeypox), Smallpox
Phase 2RecruitingBioNTech SE3102026-02-202026-08-11
Prospective Follow-up After MVA-BN Booster Vaccination
Monkeypox (Mpox)
Not yet recruitingInstitute of Tropical Medicine, Belgium952026-01-152026-01-20
Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo
MVA-SIBP low dose, MVA-SIBP high dose, MVA-BN - Monkeypox (Mpox)
Phase 2Not yet recruitingShanghai Institute Of Biological Products1802025-12-312025-11-28
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
LC16m8 - Mpox (Monkeypox), Mpox
RecruitingInternational Vaccine Institute119902025-12-032026-08-31
Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts
Mpox (Monkeypox)
CompletedFundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia5502025-10-312026-05-01
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Jynneos, MVA-BN (Quail) - Monkeypox (Mpox)
Phase 2Active not recruitingBavarian Nordic9702025-10-272026-04-08
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.
BSY001 for Injection (37.5mg), BSY001 for Injection (75 mg), BSY001 for Injection (150 mg) - Smallpox, Cowpox
Phase 1RecruitingChina National Biotec Group Company Limited762025-08-282026-01-29
IDOV-Immune for Advanced Solid Tumors
IDOV-Immune (oncolytic vaccinia virus) - Colorectal Cancer, Pancreatic Cancer
Phase 1RecruitingViroMissile, Inc.782025-08-252026-08-05
Neutralizing Power of Serum Antibodies - 2
Sample collection (blood and optional nasal swab) - COVID-19, SARS-CoV-2 Viraemia
Not applicableRecruitingCentre Hospitalier Régional d'Orléans302025-08-222025-12-19
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC
Mpox vaccination with MVA-BN - Mpox (Monkeypox)
Phase 2Active not recruitingInstitute of Tropical Medicine, Belgium6002025-08-042026-11-18
Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)
Mpox (Monkeypox)
Enrolling by invitationOsaka Metropolitan University1442025-07-312025-05-29
Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC
MVA-BN standard regimen, MVA-BN standard regimen (Administered as PEP) - Neonate, Maternal Transmission
Phase 3Active not recruitingJean-Pierre Van geertruyden3592025-06-232026-01-30
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Recombinant human IL-21-expressing oncolytic vaccinia virus injection - Advanced Pancreatic Cancer
Phase 2RecruitingHangzhou Converd Co., Ltd.122025-05-292026-02-27

Showing 20 of 201. Sign in to see all of them.

Narrower conditions

Mpox, Monkeypox (72)  ·  Smallpox (71)  ·  Vaccinia (53)  ·  Molluscum Contagiosum (22)  ·  HIV Infections (19)  ·  Neoplasms (8)  ·  Colorectal Neoplasms (6)  ·  Melanoma (6)  ·  Carcinoma, Hepatocellular (5)  ·  Cowpox (5)  ·  Liver Neoplasms (5)  ·  Virus Diseases (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  Ovarian Neoplasms (4)

Broader conditions

DNA Virus Infections (200)  ·  Infections (198)  ·  Virus Diseases (196)  ·  Animal Diseases (74)  ·  Primate Diseases (72)  ·  Rodent Diseases (72)  ·  Skin and Connective Tissue Diseases (32)  ·  Skin Diseases (29)  ·  Urogenital Diseases (27)  ·  Genital Diseases (25)  ·  Neoplasms by Site (25)  ·  Skin Diseases, Infectious (24)  ·  Immune System Diseases (23)  ·  RNA Virus Infections (23)

Interventions

smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (32)  ·  tecovirimat (15)  ·  Smallpox Vaccine (11)  ·  VaxSyn HIV-1 (gp160) vaccine (8)  ·  HIVAC-1e (6)  ·  Blood Specimen Collection (4)  ·  DryVax vaccine (4)  ·  berdazimer sodium (4)  ·  VP-102 (3)  ·  smallpox vaccine LC16m8 (3)  ·  130-nm albumin-bound paclitaxel (2)  ·  ACAM2000 (2)  ·  Bevacizumab (2)  ·  Cantharidin (2)  ·  Cisplatin (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (40)  ·  Bavarian Nordic (13)  ·  Institute of Tropical Medicine, Belgium (9)  ·  Emergent BioSolutions (8)  ·  SIGA Technologies (8)  ·  Jennerex Biotherapeutics (7)  ·  Sanofi Pasteur, a Sanofi Company (5)  ·  Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (4)  ·  Genelux Corporation (4)  ·  Novan, Inc. (4)  ·  Seoul National University Hospital (4)  ·  ANRS, Emerging Infectious Diseases (3)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" (3)  ·  Osaka Metropolitan University (3)

Countries

United States (105)  ·  Democratic Republic of the Congo (22)  ·  France (16)  ·  South Korea (9)  ·  Canada (8)  ·  Germany (8)  ·  Spain (7)  ·  China (6)  ·  United Kingdom (6)  ·  Belgium (5)  ·  Russia (4)  ·  Brazil (3)  ·  Italy (3)  ·  Mexico (3)  ·  Switzerland (3)

Top investigators

Belshe R (5)  ·  Clements ML (3)  ·  Couch R (3)  ·  Dolin R (3)  ·  Laurens Liesenborghs, MD (3)  ·  Levine M (3)  ·  Vladimir I. Kuzubov, PhD (3)  ·  Wright P (3)  ·  Corey L (2)  ·  David Kirn, MD (2)  ·  Dennis Hruby, Ph.D. (2)  ·  Dennis Hruby, PhD (2)  ·  Edgar T Overton, MD (2)

Results publications

PMID 36263798, PMID 32965495, PMID 33599960, PMID 34909721, PMID 34976290, PMID 36408618, PMID 37227734, PMID 42372625, PMID 11874634, PMID 14517111, PMID 14577912, PMID 14647116, PMID 15069910, PMID 15635137, PMID 17597266, PMID 18495536, PMID 19935776, PMID 19944151, PMID 20214479, PMID 20350190, PMID 20350191, PMID 20466416, PMID 20600480, PMID 21921208, PMID 22011376, PMID 22113474, PMID 23349878, PMID 23393196, PMID 23482644, PMID 23664987, PMID 25879867, PMID 26439129, PMID 27327616, PMID 27851688, PMID 28256358, PMID 29652929, PMID 29773661, PMID 29972742, PMID 30445121, PMID 31413923, PMID 32057574, PMID 32967791, PMID 33143690, PMID 33400412, PMID 33675226, PMID 34454787, PMID 34686353, PMID 35491738, PMID 35830173, PMID 36287306

NIH funding

U54AI057159 (2)